Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation is a research paper published in Science (2020). On theSindex it has a DataRank of 1.4. It has been cited 9,736 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.4
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases
Grant: R01-AI127521
NIAID NIH HHS
Grant: R01 AI127521
National Institutes of Health
Grant: 5R01AI127521-03
Structure, Function and Antigenicity of Coronavirus Spike Proteins
FWCI
209.94
Citation Percentile
1.0%
Influential Citations
584
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Stable trimer formation of spike protein from porcine epidemic diarrhea virus improves the efficiency of secretory production in silkworms and induces neutralizing antibodies in mice
Additional file 2 of Stable trimer formation of spike protein from porcine epidemic diarrhea virus improves the efficiency of secretory production in silkworms and induces neutralizing antibodies in mice
Additional file 1 of Stable trimer formation of spike protein from porcine epidemic diarrhea virus improves the efficiency of secretory production in silkworms and induces neutralizing antibodies in mice
Additional file 1 of Stable trimer formation of spike protein from porcine epidemic diarrhea virus improves the efficiency of secretory production in silkworms and induces neutralizing antibodies in mice
Additional file 2 of Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2)
Additional file 2 of Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2)
Additional file 2 of COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection
Additional file 2 of COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection
Additional file 6 of Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
Additional file 6 of Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
Additional file 1 of IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
Additional file 1 of IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
Additional file 1 of Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis
Additional file 1 of Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis
Additional file 1 of Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models
Additional file 1 of Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models
Additional file 3 of Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models
Additional file 3 of Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models
Additional file 1 of ACE2: the molecular doorway to SARS-CoV-2
Additional file 1 of ACE2: the molecular doorway to SARS-CoV-2